Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Singer, Gad

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. [electronic resource] - Journal of the National Cancer Institute Mar 2003 - 484-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0027-8874

10.1093/jnci/95.6.484 doi


Codon
Cystadenocarcinoma, Papillary--genetics
Female
Genes, ras
Humans
Mutation
Ovarian Neoplasms--genetics
Proto-Oncogene Proteins c-raf--genetics